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INTRODUCTION 
The lactose in milk is a principal source of calories for children 
and this disaccharide is important food for adult nutrition in many areas 
of the world. However, the ability of some children and adults to di­
gest lactose is severely limited because they totally lack or only have 
trace amounts of the intestinal enzyme, lactase, a specific intestinal 
beta-galactos i dase. 
Milk is a nearly complete human food and in powdered form can be 
conveniently stored and shipped long distances. Therefore, it is a 
popular source of protein and other nutrients in many programs of aid 
to nutritionally impoverished children including American Blacks. The 
discovery that many of these children are physiologically unable to 
utilize lactose is thus a matter of grave concern and its implications 
are being investigated by such agencies as the United States Office of 
Child Development and the Protein Advisory Group of the United Nations. 
In persons possessing intestinal lactase, lactose is hydrolyzed into 
glucose and galactose. These components are then absorbed by the epi­
thelial cells of the small intestine and transmitted to the blood stream. 
Individuals that suffer from lactase deficiency are unable to digest 
lactose and become ill after consuming it. The malady that results from 
an inability to digest lactose is referred to as lactose intolerance. 
The enzyme is not present in the intestine of the embryo or fetus un­
til the middle of the last stages of gestation. Its activity attains a 
maximum instantly after birth. Thereafter, it begins to decrease reaching 
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extremely low levels after one and a half to three years in most children. 
The exact mechanisms involved in the appearance and disappearance of the 
enzyme activity are not known. 
Lactase is also present in mammals other than man in the fetus be­
fore birth and in infancy. In these animals the enzyme, as in the human, 
has its highest activity immediately after birth and begins to decline 
rapidly reaching very low levels instantly after weaning. The "normal" 
condition for mammals is not to have the enzyme as adults. 
The nucleus of a cell has many functions. One of the most important 
is the process of gene transcription whereby information encoded in the 
deoxyribonucleic acid (DNA) is utilized in the synthesis of complementary 
molecules of ribonucleic acid (RNA). It is through the synthesis of 
messenger RNA (mRNA) that the genetic information stored in the nuclear 
DNA is ultimately transmitted to the protein synthesizing machinery of 
the cytoplasm. The coded message of mRNA is used to direct the trans-
lational synthesis of specific proteins. 
Specific regulation of the process of gene transcription is ex­
tremely important during both the development and normal functioning of 
cells of higher organisms. For example, differentiated cells that per­
form different functions utilize characteristic sets of genetic infor­
mation, and so must use different regions of the genome for the synthe­
sis of mRNA (Stein et , 1974). Since the DNA of each cell in a 
multicellular organism appears to be the same, this means that various 
cell types use the information contained in this DNA differently. Spe­
cific regulatory mechanisms must, therefore, be available for activating 
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particular regions of the genome for mRNA synthesis, depending on the 
needs of the cell. 
In humans the functional lactase activity is "turned on" in the 
fetus in the latter stages of gestation and abruptly "turned off" in 
early childhood. For the purposes of this study it was assumed that the 
gene(s) coding for the lactase enzyme in mammalian cells are under some 
form of regulatory genetic control. 
The objective of this study was to establish a mammalian cell line, 
in culture, that actively produces the lactase enzyme. Such a cell sys­
tem would permit extensive investigation of the nature of this mammalian 
disaccharidase and give some insight into the control systems regulating 
its cellular synthesis. 
All lines of cultured mammalian cells perform a variety of biosyn-
thetic activities, including synthesis of purine and pyrimidine nucleo­
tides, DNA, RNA, seven of the 20 structural amino acids and both struc­
tural and enzymatic proteins. Many enzymes can be assayed and their 
kinetic properties, inhibition characteristics and thermal stabilities 
studied. The enzymatic defects associated with a number of inherited 
metabolic defects have been demonstrated in work with cell cultures. 
The lactase enzyme is ordinarily present only in the mucosal 
(epithelial) cells of the small intestine. In an attempt to establish 
a mammalian cell line capable of producing the lactase enzyme, the 
following approaches were used: 
1. An attempt was made to reverse this natural lactase differentiation 
(expression of the enzyme only in epithelial cells of the small in­
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testine) by using another cell type, an established white blood cell 
line, in which the genetic potential for lactase production is pre­
sent although not expressed. These latter cells were exposed to 
both mutagenic agents and chemical compounds that have been shown to 
have varying degrees of control over certain differentiated cell 
characteristics in some mammalian cells grown in culture. 
2. An attempt was made to provoke lactase activity in a previously 
established small intestinal cell line. The cells of this line, 
maintained in culture since 1957, were derived from cells which 
naturally would have been expected to produce the lactase enzyme 
in vivo. Enzyme induction was attempted by treatment of the cells 
with lactose and other enzyme inducers. 
3. An attempt was made to establish a new small intestinal epithelial 
cell line from fetal mice. These cells would be expected to retain 
their natural in vivo lactase activity in vitro. 
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REVIEW OF LITERATURE 
The Lactase Enzyme and Lactose Intolerance 
Physicians have long recognized that certain individuals do not 
tolerate milk, that they become ill after consuming it. Though such ill­
ness has frequently been diagnosed simply as milk allergy, today the ill­
ness can usually be traced to other forms of milk intolerance. One of 
the causes of milk intolerance is related to the inability of the body 
to hydrolyze lactose. This form of intolerance is occasionally detected 
in infants, and some researchers suspect that it is an acquired defect, 
secondary to acute gastroenteritis; however, with age, such infants are 
usually able to tolerate larger quantities of milk without distress. 
Intolerance also occurs in adults, who in infancy and childhood, drank 
milk without ill effect. This adult type of intolerance, which has its 
onset after weaning and its origin in lactose malabsorption, is the sub­
ject of this review. 
The lactase enzyme 
In 1963, (Dahlqvist et al. ; Auricchio et ) it was conclusively 
proved by intestinal biopsy that adult lactose malabsorption is caused by 
a deficiency of the enzyme, lactase, (a specific intestinal beta-galacto-
sidase) in the small intestine where lactose digestion and absorption 
occur. Subsequent studies on biopsy material of human small intestines 
indicated that there are three intestinal beta-galactosidases (Asp and 
Dahlqvist, 1972; Asp, 1965; Asp et aj^., 1969; Gray and Santiago, 1969; 
Gray et al_., 1969). 
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The first enzyme, the lactase, is a brush border (microvilli) enzyme 
with an optimum pH 5.5-6.0 and a molecular weight of approximately 
280,000. Lactose is the preferential substrate. The second enzyme, the 
acid beta-galactosidase is thought to be lysosomal and has an optimum pH 
of 4.0-4.5 and a molecular weight of 156,000-600,000. It has the broadest 
substrate specificity of the three enzymes hydrolyzing a number of syn­
thetic beta-galactosides (0-nitrophenyl-B-galactoside, 6-bromo-2-naphtyl-
B-galactoside, P-nitrophenyl-B-galactoside) as well as lactose in vitro. 
The third enzyme, the hetero-B-galactosidase has optimum pH 5.5-6.0 and 
a molecular weight of 80,000. This enzyme hydrolyzes synthetic B-galac-
tosides but not lactose. Similar enzymes have also been found in calf 
(Heilskov, 1956), rabbit (Doell and Kretchmer, 1962) and rat (Dahlqvist 
et , 1965; Koldovsky and Chytil, 1965; Koldovsky et aQ_., 1965). 
Density gradient ultracentrifugation of intestinal material from 
lactose intolerant patients (Gray et , 1969; Asp and Dahlqvist, 1972) 
demonstrated the absence of a beta-galactosidase with an optimum pH of 
5.5-6.0 and a molecular weight of 280,000 which was therefore assumed to 
be lactase. The other two enzymes were found at normal levels. These 
studies showed that primary adult lactose intolerance is most probably 
due to a deficiency of brush border lactase. Since enzyme three has a 
pH optimum identical with that of the lactase. Gray et al_. (1969) sug­
gested that this enzyme may be a precursor of lactase. However, there is 
no evidence to support this suggestion. 
The lactase enzyme is not present in the intestine of the mammalian 
embryo or fetus until the middle of gestation (Kretchmer, 1972). Its 
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activity attains a maximum immediately after birth. Thereafter it de­
creases, reaching a low level immediately after weaning in the rat and 
after one and a half to three years in most children. 
The metabolic function of lactase and lactose intolerance 
The primary function of brush border lactase is the breakdown of 
lactose into its component monosaccharides, glucose and galactose, in the 
jejunum of the small intestines. In normal individuals, the lactose is 
hydrolyzed into its constituent monosaccharides and they are then absorbed 
by the epithelial cells and transmitted to the blood stream. Thus, at 
some time shortly after ingestion of lactose by individuals who possess 
brush border lactase, there would normally be a measurable rise in the 
amount of glucose and galactose in the blood. This provides one means of 
determining whether an individual suffers from lactase deficiency. If a 
person is suspected of having a lactase deficiency he is administered a 
lactose tolerance test (LTT). The presence of less than 20 mg/100 ml of 
blood glucose following an oral dose of 50 grams of lactose usually indi­
cates lactase deficiency. One would expect a considerable rise in blood 
glucose if lactose were utilized. This is confirmed by a glucose-galac­
tose test. If the patient is fed these two monosaccharides as such, and 
then experiences a significant rise in blood sugar, it demonstrates that 
he is able to absorb the hydrolyzed components of lactose, and implies 
that his difficulty is an inability to hydrolyze lactose because of lac­
tase deficiency. A second means of demonstrating lactase deficiency is 
biopsy of the intestinal mucosa and direct ascertainment of the amount of 
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lactase present. A third, less frequently used means, is interpretation 
of an abdominal radiograph taken an hour after the subject ingests a lac-
tose-barium sulphate mixture. Generally, the radiograph of a lactase de­
ficient person is quite distinctive (Simoons, 1969). 
If the amount of lactose presented to the intestinal cells exceeds 
the hydrolytic capacity of the available lactase, a portion of the lac­
tose remains undigested. Some of it passes into the blood and eventu­
ally is excreted in the urine. The remainder moves on into the large in­
testine where two processes ensue. One is physical. The lactose mole­
cules increase the particle content of the intestinal fluid compared with 
the fluid in cells outside the intestine and therefore by osmotic action 
draw water out of the tissues into the intestine. The other process is 
biochemical. The lactose is fermented by the bacteria in the colon. Or­
ganic acids and carbon dioxide are generated and the symptoms are a bloat­
ing feeling, flatulence, belching, cramps, and a watery explosive diarrhea 
(Kretchmer, 1972). 
Any disease such as sprue and celiac disease that injures the mucosa 
of the small intestine also injures the disaccharidases, among them lac­
tase, that are located there. Thus, an incidental adult lactase deficien­
cy may develop when an individual contracts such a disease; and, in tro­
pical sprue it may persist long after other symptoms of the disease have 
returned to normal (Bayless e^ al_., 1964; Gray e;t^., 1968). This re­
view is concerned only with the primary form of adult lactase deficiency 
that occurs in healthy individuals who have every indication of normalcy 
of the small intestinal mucosa, who have no history of intestinal disease 
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or damage, and who have other disaccharidases in normal quantities. 
The adult who suffers from primary lactose intolerance can consume 
small quantities of milk, as in tea or coffee, without difficulty. Though 
individuals differ in the amount of milk needed to bring on symptoms, one 
or more glasses may cause abdominal distension, discomfort and pains in 
the mal absorber, and larger quantities may cause diarrhea, with or without 
cramps. Since an individual would normally relate milk intake to his 
symptoms, which generally begin 30 to 90 minutes after consumption, he 
would usually eliminate milk from his diet or confine consumption to 
manageable amounts which would end his symptoms. Others would avoid fresh 
milk and instead consume those products such as yogurt, butter and ghee 
in which the lactose has been broken down by bacterial fermentation or has 
been removed by washing, thus permitting consumption without ill effect. 
The nutritional effects of reduction in milk consumption by the lac­
tose intolerant individual have been investigated but far more study is 
needed. The lactose intolerant individual is denied the protein and cal­
cium from milk forcing him to supplement from other sources or suffer de­
ficiency. In addition to being an energy source, lactose has been shown 
to aid calcium absorption (Simoons, 1969). It has been suggested that the 
disease, osteoporosis, is associated with reduction of milk consumption by 
the intolerant individual. 
Group differences in lactose tolerance 
The earliest research on lactase deficiency carried out mainly in 
the United States and in Europe led to the erroneus belief that in nor­
mal humans everywhere lactase production remains at a high level through 
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life which permits milk consumption without adverse effect regardless of 
age. This view is found in the literature at least into the mid 1960's 
(Haemmerli et al., 1965; Haemmerli and Kistler, 1966, 1967). Since this 
time researchers have become aware of significant group differences among 
adults in lactase deficiency and in lactose intolerance. 
In the United States, where much of the pioneering research of the 
late 1960's was done at the John Hopkins University School of Medicine, 
striking differences were demonstrated between white and Negro adults. 
One study (Bayless and Rosensweig, 1966, 1967; Rosensweig and Bayless, 
1966) of 40 healthy, volunteer prisoners, 20 white and 20 Negro, who were 
chosen consecutively, showed that 95% of the Negroes but only 10 percent 
of the whites reported having experienced symptoms of milk intolerance in 
the past; lactose tolerance tests indicated that 90 percent of the Negroes 
and 10 percent of the whites were lactose mal absorbers; and intestinal 
biopsies revealed that 70 percent of the Negroes and five percent of the 
whites were lactase deficient. Most of the milk intolerant individuals 
reported consuming milk in their youth, many drinking a quart or more 
daily without ill effect, and they also spoke of an onset of symptoms in 
adolescence or in their early twenties. A subsequent study (Huang and 
Bayless, 1967) was made of 20 Black and 20 white children, who ranged in 
age from 11 months to 11 years, all healthy and chosen at random from 
children attending a Baltimore pediatric clinic; their families were all 
of a comparable socioeconomic level. The results were similar. Moreover, 
data from earlier studies indicated that with age there was a decrease in 
lactase among healthy Black Americans, whereas most healthy white Americans 
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had a constant level of lactase regardless of age. 
Another study (Welsh et , 1967) of 170 patients from medical 
centers in Oklahoma, Texas, and Nebraska showed a lactase deficiency, 
not only significantly higher in Blacks (77 percent) than in whites (19 
percent), but also higher in American Indians (67 percent) than in whites. 
An investigation of 20 healthy adult Orientals (Huang and Bayless, 1968) 
residing in the United States revealed that 70 percent of the subjects 
experienced symptoms of malabsorption after ingesting one or two glasses 
of milk; and that 95 percent had symptoms after consuming lactose equal 
to the amount contained in a quart of milk. All the Orientals had drunk 
milk without symptoms as infants and most reported the onset of symptoms 
in adolescence or later. Of a control group of healthy white Americans, 
only 10 percent were intolerant of lactose. A high incidence of lactase 
intolerance among healthy Orientals in American was confirmed by lactose 
tolerance tests. One hundred percent of those tested were found to be 
lactase deficient (Chung and McGill, 1968). 
In a study conducted among various tribal groups in East Africa 
(Cook and Kajubi, 1966) parallel differences were demonstrated. Lactose 
tolerance tests were performed on 135 adults and children and lactase 
determinations were made from intestinal biopsy for 54 of the subjects. 
Striking differences were found between the primarily agricultural Ganda 
of Uganda, along with neighboring agricultural tribes who are also of 
Bantu speech, and certain nearby peoples of nomadic tradition, i.e., the 
Hamitic Hima of Uganda and Tussi of Rwanda. Analysis of the data pre­
sented for Bantu agriculturists and the nomadic Hamites revealed that 
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the Ganda and their neighbors have a high incidence (90 percent) of 
adult lactose intolerance, whereas the Hima and Tussi have quite low in­
cidences (9 percent and 16 percent). The agricultural Hutu of Rwanda and 
the Iru of the Ankule district of Uganda, who are presumed to be of mixed 
Bantu/Hamitic origin, have intolerance levels (33 to 38 percent) that are 
intermediate between those of the other Uganda Bantu agricultural tribes 
and those of the Hamitic peoples. These results were confirmed by in­
testinal biopsies and subsequent studies of members of the same tribe 
(Cook, 1967; Cook et al_., 1967; Cook and Howels, 1968; Cook and Dahlqvist, 
1968). 
There have been only a few investigations of lactose intolerance 
among Asians. In one of these (Davis and Bol in, 1967; Bol in et al., 
1968; Bolin and Davis, 1969) however, the results parallel those previous­
ly mentioned for Orientals in the United States (Huang and Bayless, 1968; 
Chung and McGill, 1968). This study involved students living in Australia, 
among them 30 Chinese, five Indians. Twenty-three asymptomatic white 
Australians were used as a control group. Whereas no member of the control 
group proved to be lactose intolerant, 90 percent of the Chinese and 80 
percent of the Indians did. Another Indian study by Desai et (1967) 
gave similar results. 
Four studies (Halsted et , 1969; Gilat et al_., 1971; Pena Yanez 
et^., 1971; Rotthauwe et , 1971) have confirmed the existence of a 
generally high incidence of lactose intolerance and lactase deficiency 
among Arabs. These studies indicate that approximately 80 percent of 
the Arab population suffer from primary adult lactase deficiency. 
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A high incidence of adult lactose intolerance has also been confirmed 
among Jews in Israel. Rozen and Shafrir (1968) found that 57 of 93 (61 
percent) adult Israeli Jews, mainly clinic patients, had low rises in 
glucose during the LIT. Gilat et al_. (1970) used lactose tolerance tests 
to check 217 Israeli Jews. Sixty-three of the 217 were also biopsied to 
determine lactase deficiency. Overall, 71 percent of those given LTT were 
lactose intolerant, and 60 percent of those biopsied were lactase defi­
cient. Leichter (1971) also reported similar findings among Canadian and 
American Jews. 
In Europe, the only evidence of widespread lactose intolerance among 
an ethnic group is found among Greeks. Many of them are said to have 
milk intolerance and in one study, 15 of 17 Greek Cypriots, who were with­
out gastroenterological problems, proved to be lactose intolerant 
(McMichael et al^.. 1965). By contrast, of 90 Northwest Europeans (British, 
Irish, Scandinavian, and German), only 11 persons, or 12 percent were mal-
absorbers. The latter figure is comparable to that reported for white 
Americans who are predominantly of Northwest European ancestry. 
The above studies (summarized in Table 1) indicate that many more 
groups all over the world are intolerant to lactose than are tolerant. 
Real adult tolerance to lactose has so far been observed only in Northern 
Europeans, approximately 90 percent of whom tolerate lactose, and in the 
members of two nomadic, pastoral tribes in Africa, of whom about 80 per­
cent are tolerant (Kretchmer, 1972). Although other generally tolerant 
groups may be found, they can only belong to a minority segment of the 
human species since Orientals and people of African descent constitute 
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Table 1. Prevalence of adult lactase deficiency in human population 
subgroups 
Percent Lactase 
Group Deficient Reference 
American White 10.0 Bayless and Rosensweig, 
1966, 1967; 
Huang and Bay!ess, 1967. 
American Black 70.0 Bayless and Rosensweig, 
1966, 1967; 
Rosensweig and Bayless, 
1966; 
Welsh et al_., 1967. 
American Indian 67.0 Welsh e1^ al_., 1967. 
American Jew 79.0 Leichter, 1971. 
Israeli Jew 71.0 Rozen and Shafrir, 1968; 
Gil at et , 1970. 
Oriental 100.0 Huang and Bayless, 1968; 
Davis and Bol in, 1967; 
Bol in et al., 1968; 
Chung andTîcGill, 1968. 
Indian 80.0 Desai, et , 1967. 
African Bantu 90.0 Cook and Kajubi, 1966; 
Cook, 1967; 
Cook et , 1967. 
Arab 80.0 Hal stead et ^., 1969; 
Gilat et ^., 1971 ; 
Pena Yanez el^ al., 1971 ; 
Rotthauwe et aT7, 1971. 
Greek 88.0 McMichael et al., 1965. 
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the majority of the world's population. 
The basis for group differences in lactose tolerance 
Among the possible hypotheses for explaining these differences in 
adult lactose tolerance are the following: 
1. That some ethnic groups have a high incidence of the specific 
diseases which damage the intestinal mucosa and inhibit lactase 
production, and that, even after affected individuals have re­
covered and are in apparent good health, the effects remain. 
If this explanation is correct, group differences in lactose 
tolerance would reflect differences in the incidence of such 
diseases (the disease hypothesis). 
2. That drugs or other items of diet inhibit lactase production. 
In this view, group differences in lactose tolerance derive 
from contrasts in the consumption of such inhibitors (the hy­
pothesis of dietary inhibition). 
3. That an individual's production of lactase and his ability to 
hydrolyze lactose normally decreases with age unless milk is 
consumed (the hypothesis of lactase induction by milk con­
sumption). 
4. That the group differences are genetic in origin (the genetic 
hypothesis). \ 
The disease hypothesis It is difficult to assess the role of 
disease in contributing to group differences in lactose tolerance. It is 
recognized that there is widespread subclinical disease of the small 
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intestine among symptom-free and seemingly normal individuals in various 
tropical countries, and that the intestinal mucosa of affected individuals 
are altered in form and absorptive ability (Lindenbaum e^^., 1966; 
England, 1968; Sheehy et , 1968). There must be among the world's 
peoples differences in the incidence of subclinical disease, as well as in 
the more severe clinical forms of disease that induce malabsorption of 
lactose (Simoons, 1969). It is also claimed that of all the dissachari-
dases, lactase is the most readily affected by damage to the intestinal 
mucosa and is the slowest to recover (Chandra e^^., 1968; Holzel, 1968). 
One of the diseases in which there commonly is an intolerance of 
lactose is kwashiorkor, one form of severe protein-calorie malnutrition. 
Children ill with kwashiorkor almost always have diarrhea, and in Africa 
it has been demonstrated that in many patients, the diarrhea can be con­
trolled by the removal of milk from the diet (Bowie et al^., 1963). The 
milk intolerance of the African kwashiorkor patient has also been shown 
to derive from an intolerance of lactose and a deficiency of lactase. 
It has been suspected (Bowie et 1965; Bowie et al., 1967) that the 
lactase deficiency is secondary to the disease, and that it develops be­
cause of intestinal mucosal damage brought on by protein deprivation. 
Since the lactase deficiency continues to be found in some Africans long 
after they have recovered from the illness (Bowie et al_., 1967; Cook and 
Lee, 1966), kwashiorkor would seem to contribute to adult lactose in­
tolerance. 
However, subsequent studies challenged this and certain other as­
pects of the kwashiorkor/lactase relationship. Work with rats (Solimano 
17  
et al^., 1967; Prosper et aT_., 1968) showed that protein deprivation does 
not significantly decrease lactase or other intestinal disaccharidase 
activities. A species difference could be present, or the case may be 
that something other than protein deprivation is responsible for the 
lactase deficiency that occurs in kwashiokor. In another study of 
Indian infants and children suffering from protein-calorie malnutrition, 
(Chandra et , 1968) it was found that all but four of the 39 who had 
been lactose intolerant were able to hydrolyze lactose after recovery 
from malnutrition. Of the four, three had a parent who was lactose in­
tolerant which suggested that the intolerance was inherited; and there 
was a possibility that the fourth also had an inherited inability to 
absorb monosaccharides. The results of this study open the possibility 
that the African children who had long recovered from kwashiorkor but 
remained lactose intolerant were so before becoming ill. 
Further study is needed before the relationship of kwashiorkor to 
lactose intolerance is fully understood. It is clear, however, that in 
whatever way kwashiorkor or other diseases may contribute to group dif­
ferences in lactose tolerance among adults, this can be only one element 
in the situation, for another important question remains unanswered. 
Why should there be significant differences in lactase production and 
lactose tolerance among groups living in the same environment, both 
tropical and subtropical, and who have been exposed to similar risks of 
disease and intestinal damage? For example. Blacks, Orientals and whites 
living in America or Hamitic and Bantu peoples in East Africa? Why 
should there be this disparity among these healthy adults who show no 
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evidence of jejunal abnormality and who can absorb sugars other than 
lactose without difficulty? 
The hypothesis of dietary inhibition This hypothesis, as ad­
vanced by Sunshine (1964), is based on the observation that taking the 
drug, colchicine, decreases an individual's lactase production and that 
he then becomes ill if he drinks milk. The idea is that foods or drugs 
may contain similar lactase-inhibiting substances and that the differing 
ethnic consumption patterns create group differences in lactose tolerance. 
There is no evidence in the literature to support this theory. A similar 
concept was set forth by Sprinz e;t (1962). This investigator sug­
gested that highly spiced foods and betel nut consumption may alter the 
intestinal mucosa and contribute to malabsorption. Since research has 
not been carried out on diet as a possible contributory factor to group 
differences in absorption of lactose or other sugars, such hypotheses 
can only be regarded as being highly speculative. 
Hypothesis of lactase induction by milk consumption The ques­
tions are: (1) whether it is normal for an individual's lactase pro­
duction and lactose absorption to decrease after weaning and, if so, 
whether lactase production can be made to persist throughout life if the 
individual continues to consume lactose after this time; (2) whether 
group differences in adult lactose tolerance have their origin in the 
contrasts of group difference in milk consumption that are evident after 
weaning. 
The possibility of individual adaption to lactose has been considered 
since the beginning of the century, usually through attempts to relate 
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lactase activity to the concentration of milk in the diet of nursing 
animals. A number of animal studies may be found in the literature 
(Simoons, 1969; Broitmann e1^^., 1968; Cain et , 1968; Reddy et al., 
1968; Huber et aly, 1961; Doell and Kretchmer, 1962; Ruber et al_., 1964; 
Fischer and Sutton, 1953; Plinmer, 1906). Unfortunately, the studies 
have been quite different in design and execution, in the species of 
animal used, in the amount of lactose fed, in the length of time for 
which the experiment continued, in the timing of biopsies, in the part of 
the intestine biopsied, in the method of enzyme assay, and in other ways. 
All of these differences make it difficult to compare the results. 
Despite this difficulty, certain conclusions can be drawn from these 
experiments: (1) Lactase production continues in the animal intestine 
even if all lactose is eliminated from the diet (Huber et , 1961) 
(2) If an animal continues to receive lactose during and after weaning, 
there may be a delay in the normal drop of lactase activity with age 
(Simoons, 1969). (3) Lactase levels in adult animals are much lower 
than those of their infancy, and it has been demonstrated that throughout 
life they can not be maintained at a consistently high level by lactose 
feeding (Simoons, 1969; Doell and Kretchmer, 1962). (4) Lactose feeding 
can lead to a proliferation of the intestinal mucosa of nursing animals 
and an increase in the total lactase activity of the small intestine 
(Huber et , 1964). (5) Some previously weaned animals have an in­
crease in specific lactase levels as a result of feeding on rations that 
are extremely high in lactose (Cain et al_., 1968; Broitmann e;t al_., 1968). 
However, (6) it has not been clearly ascertained whether lactose feeding 
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actually induces activity of the lactase enzyme or whether there is simply 
a decrease in breakdown as suggested by Reddy et (1968). 
Simoons (1969) questions the relevance of the animal experiments to 
the human situation. The lactose of cow's milk, the form of milk most 
commonly used by man, is usually between 4.5 and 5.0 percent by weight. 
The animal experiments, however, commonly have involved diets containing 
25 or 30 percent lactose, at least five times the amount of lactose in a 
diet composed only of milk. It is inconceivable that under day to day 
conditions, man could consume lactose in these amounts. 
Some of the evidence on lactase induction in humans is experimental, 
some circumstantial. Investigations of lactase activity in human fetuses 
and the newborn (Heilskov, 1951; Auricchio ^ , 1965) demonstrate that 
lactase is not present in the intrauterine stage and increases to high 
levels shortly before birth. Since the unborn child does not consume 
milk, this increase in lactase level must be brought about by something 
other than lactose. With reference to induction of lactase in adults, 
a number of studies have been done (Cuatrecasas et al^., 1965; Knudsen 
et , 1968; Kogut et al_., 1967; Rosensweig and Herman, 1969; Dunphy 
et aj[., 1965; Bayless and Rosensweig, 1966, 1967; Jersky and Kinsley, 
1967; Chung and McGill, 1968). These studies suggest the following: 
1. That in humans the intestinal lactase level is independent of 
the amount of lactose consumed. 
2. That an absence of milk from the diet does not depress lactase 
levels, nor does its presence increase it. 
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3. That among most European peoples the persistence of high 
levels of lactase into adulthood derives from other causes. 
The genetic hypothesis The premise that group differences in 
adult lactose intolerance are genetic in origin is supported by an over­
whelming majority of researchers in medicine and related fields. It is 
difficult to conceive of an explanation other than genetic that can 
account so readily for the persistence of high levels of intolerance among 
Blacks and Orientals in the United States, an environment strikingly dif­
ferent from those of their ancestral homelands. 
To prove a genetic etiology, complete family histories are needed. 
At present the literature contains only a few such studies (Ferguson 
and Maxwell, 1967; Welsh e^^., 1968; Flatz and Saengudom, 1969; Welsh, 
1970; Gilat et al_., 1973). Taken together these studies report a total 
of only 42 families in which both parents and one or more of their off­
springs were subjected to lactose tolerance tests and lactase assay. 
Representative pedigrees for some of the families studied are given in 
Figures 1-3. The results of these studies strongly indicate a genetic 
etiology for primary adult lactose intolerance. 
The mode of inheritance is not completely clear. However, it has 
been suggested by Ferguson and Maxwell (1967) and others (Fine et al., 
1968; Flatz and Saengudom, 1969) that primary adult lactase deficiency is 
inherited as an autosomal recessive trait. Three alleles were postulated: 
L (normal, dominant), l-j and Ig (both recessive). It has been assumed 
that genotypes LL, Ll^ and Llg result in the normal phenotype; l-jl^ in 
primary adult lactase deficiency and Iglg in the rare alactasia (congen-
Figure 1. Results of lactose tolerance tests and lactase 
assays in five pedigrees from Welsh et al. 
(1968) (A) and Ferguson and Maxwell TTSST) (B) 
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Figure 2. Results of lactose tolerance tests and lactase 
assays in five pedigrees (Welsh, 1970) 
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Figure 3. Results of lactose tolerance tests and lactase 
assays in six pedigrees (Gilat et al_., 1973) 
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ital lactase deficiency). A trait is usually considered to be inherited 
as a recessive if it is found in the offspring of parents who lack the 
trait. There were only two families (Figure IB and family 17, Figure 3) 
in the above studies in which this was the case. Data from these two 
families alone is not sufficient to conclude that primary adult lactase 
deficiency is inherited as a Mendelian recessive. 
The critical families for testing this mode of inheritance would be 
those in which both parents have lactase deficiency. Being presumably 
homozygous for the recessive gene, all their offspring should also have 
lactase deficiency. Welsh et (1968) studied two such families 
(Figure 1, families 1 and 2) and determined that all the siblings were 
deficient. Welsh (1970) also studied two such families (Figure 2, 
families C and D) and found all the children to be deficient. However, 
Gilat et al^ (1973) studied 11 such families; in two of the families 
(Figure 3, families 2 and 31) he found that not all the children were 
deficient. These findings provide some argument against recessive in­
heritance, but Gilat and his colleagues suggested that this discrepancy 
could have been due to an error in interpretation of the lactose toler­
ance tests or that one of the parents could have had secondary lactase 
deficiency (deficiency due to intestinal injury). Even if Gilat's argu­
ments should prove true, many more family studies are needed before final 
statements of recessive inheritance can be made. 
The conclusion that can be drawn at present is that the racial dif­
ferences which have been shown to be correlated with lactose intolerance 
are almost certainly genetic in origin. 
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Alterations of Genotypes in Cell Culture 
For more than 30 years, it has been known that human and other 
mammalian cells could be grown in vitro much in the same manner as micro­
organisms. The techniques of tissue and cell culture have now advanced 
to the point where it is relatively easy for the investigator to study and 
obtain valuable information relating to a number of diverse biological 
functions. Among these are growth, differentiation, metabolism, the ge­
netics of mammalian cells, and the metabolic basis of inherited diseases. 
One tool applied in studies in the areas mentioned above is the al­
teration of genotypes of cells grown in culture and the observation of 
the effect that these alterations or changes have on the particular 
function in question. 
Mutagenesis 
Changes in the genotype of cultured mammalian cells are usually in­
duced by treating the cells with chemical mutagens. Chemical mutagens are 
agents that alter DNA giving rise to mutations (permanent inheritable 
changes in the genetic material of organisms). 
The successful isolation of mutant or variant cells in cell culture 
requires the following: 
1. A cell line that has a relatively high cloning efficiency. Clon­
ing efficiency is the proportion of single cells, inoculated in 
low density that are capable of multiplying in number to form 
macroscopically visible colonies. The colonies can then be iso­
lated as clones which are the pure line progeny of single cells. 
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A cell line with a poor cloning efficiency hinders a reliable 
estimate of mutation frequency as well as a successful isolation 
of clones. 
2. A chemically defined growth medium. A medium that permits optimum 
cell growth. 
3. A chemical mutagen whose mode of action is known. 
4. A selection system. A method of selecting cells of altered geno­
type following the exposure of a parent population to the muta­
genic agent. There are at least four different methods for 
mutation selection in mammalian cell cultures, all of which 
are modified from the analogous selective procedures success­
fully developed in microbial genetics (Chu, 1971). These 
methods are (a) the mass selection method; (b) the lethal 
growth method; (c) the thymineless death method; and (d) the 
replica plating method. The mass selection method was used 
in this study. This procedure involves simply exposing mass 
cultures which have been treated with mutagen to extrinsic 
agents or specifically altered growth media which will not 
permit growth of nonmutagenized parental cells. The parental 
cells are nonviable in the selective environment, therefore, 
the surviving cell population should include variants having 
altered genotypes and a different phenotype. Variants thus 
isolated include those having altered carbohydrate metabolism 
(Hsu and Kellog, 1959). 
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A variant isolated in mammalian cell culture may not necessarily 
represent a true genetic alteration. For example, Terzi (1974) found 
that some apparent drug resistant mutants of mammalian cell lines were 
not true mutants, but were variants that had survived the selection 
treatment due to a temporary imbalance in chromosome number. Therefore, 
the important task after isolation from a selection experiment, is to 
determine the genetic or epigenetic nature of such variants. For soma­
tic cells the following criteria (Thompson and Baker, 1973) are applied 
to define mutant: 
1. The altered phenotype breeds true in the sense that it is stably 
transmitted through consecutive generations. 
2. The frequency of occurrence of the mutant phenotype can be en­
hanced by the application of mutagenic agents. 
3. The phenotype can ordinarily be associated with an altered gene 
product (usually a protein). 
4. The phenotype can be attributed to a specific region of the 
genome, i.£., it can be mapped in a chromosomal linkage 
group. 
Chemical compounds that effect differentiation 
If DNA directs all cell metabolism, then there are probably two 
broad categories of DNA activity during differentiation (Bischoff and 
Holtzer, 1970). First, the DNA codes for those essential molecules 
common to all cells; the respiratory enzymes and associated structural 
proteins, the enzymes synthesizing amino acids, common sugars, nucleo­
tides, and all the species of molecules required for cell multiplication. 
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The second category involves the activation of different sets of nucleo­
tide sequences in subpopulations of cells. It is this mechanism, the 
turning on or off of certain genes regulating tissue specific "luxury" 
molecules that is involved in differentiation (Holtzer e_t a]_., 1968). 
Bromodeoxyuridine and dimethyl sulphoxide are chemical compounds that 
have been shown to have differential effects on these two classes of DNA 
function. These chemicals were used in this study. 
Bromodeoxyuridine (BUDR) BUDR, a pyrimidine analogue, is incor­
porated into the DNA of dividing cells in place of thymine (Eidinoff et 
al., 1959; Djordjevic and Szybalski, 1960). The consequence of such a 
replacement in differentiating cells is a rapid inhibition of the syn­
thesis of tissue specific components. In the presence of BUDR, (1) chick 
embryo myoblasts fail to fuse and to produce myosin (Stockdale et al., 
1964; Bischoff and Holtzer, 1970); (2) chick embryo chondrocytes fail to 
initiate the production of, or lose the ability to synthesize chrondroitin 
sulfate and fail to deposit matrix (Abbot and Holtzer, 1968; Coleman et 
al., 1970); (3) mouse pancreatic cells no longer produce zymogen (Wessells, 
1964); (4) chick amnion cells fail to synthesize hyaluronic acid (Bischoff 
and Holtzer, 1968); (5) rat hepatoma cells fail to synthesize tyrosine 
aminotransferase when induced by sterols (Stellwagen and Tomkins, 1971a 
1971b); (6) chick eye pigment cells and mouse melanoma cells are inhibited 
in producing melanin (Silagi and Bruce, 1970); and (7) red blood cells 
fail to synthesize hemoglobin (Miura and Wilt, 1971). These effects are 
reversible if the exposed cells are grown in BUDR-free media or media 
supplemented with deoxythymidine. 
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A typical change in morphology accompanied the above phenomena in 
all but the rat hepatoma cells and the pancreatic cells. The cells flat­
tened inordinately and adhered more strongly to the culture dish surface, 
taking on a fibroblastic appearance. 
A most conspicuous observation is the apparent lack of effect of low 
level BUDR on essential cell functions. In general, cell growth and di­
vision are not appreciably affected. It appears that those cell functions 
associated with tissue specific molecules characteristic of a differen­
tiated state are more sensitive to BUDR than are the activities required 
for growth and cell division. 
Several sorts of models have been proposed to explain these differ­
ential effects of BUDR. Most proposals postulate that the phenotypic 
effects of BUDR are a consequence of its replacement for thymine in DNA, 
and extensive DNA density shifts have been found in myoblasts (Stockdale 
et , 1964) and rat hepatoma cells (Stellwagen and Tomkins, 1971a) 
after BUDR treatment. Really rigorous evidence that incorporation of 
BUDR into DNA is necessary for its effect is lacking. Evidence from 
synchronized cells (Wilt and Anderson, 1972) suggest that in some systems 
events associated with the S period are sensitive to the action of BUDR. 
Assuming that incorporation of BUDR into DNA is necessary for its 
action, models dealing with the phenomena must explain why it is revers­
ible and why there is selective inhibition of certain cellular functions. 
One hypothesis is that DNA containing BUDR acts as a counterfeit template 
for synthesis of informational RNA molecules and that improper messages 
are synthesized (Lasher and Cahn, 1969). This kind of mutagenic action 
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of BUDR is unlikely. The effects are all-or-none, reversible, not de­
pendent on visible light; and, as far as has been tested, abnormal pro­
teins are not synthesized. 
A second proposal postulates that DNA containing BUDR, while trans­
cribed with fidelity, is not transcribed as often as usual. Stellwagen 
and Tomkins (1971b) suggest that BUDR in DNA inhibits the transcription 
of only certain genes into messenger RNA. If this postulate is coupled 
with differential degradation of certain messengers and proteins, the 
effects of BUDR may be explained. The model is not completely satis­
factory, however, because it does not explain why transcription of cer­
tain genes is more sensitive than others. 
Finally, there is a class of models which postulate that DNA con­
taining BUDR is sufficiently different in its structure that regulatory 
controls are abortive and ineffective (Wilt and Anderson, 1972). There 
are many versions of this type of model. For instance, if there are 
regulatory elements adjacent to structural genes, such as proposed by 
Britten and Davidson (1969), the presence of BUDR in these elements could 
explain why some functions are affected more than others. A prediction of 
this type of hypothesis is that occasionally a cell function should appear 
that is not normally present e.g., interference with regulation might 
stimulate synthesis of enzymes under negative control. Koyama and Ono 
(1971) have found a 7-fold elevation of alkaline phosphatase in B-6 cells 
cultured in BUDR; this is consistent with the prediction, though not suf­
ficient to prove it. In other versions of this type of model, it has been 
suggested that the effect of BUDR may be on the structure of chromatin, 
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as opposed to just DNA (Miura and Wilt, 1971). One known effect of BUDR 
is production of chromosomal abnormalities. It could be that the presence 
of large amounts of BUDR affects binding of the chromatin proteins, there­
by perturbing the way in which some regulatory events may take place. 
All of the above mentioned hypotheses or models to explain the mech­
anism whereby BUDR exerts its effects on differentiation have some merit. 
However, at the present time, neither one is generally accepted, and the 
mode of action of BUDR on differentiated cell systems still remains a 
mystery. 
Dimethyl sulphoxidfe (DMSO) DMSO is an extraordinary organic sol­
vent with a wide range of biological activities (Leake, 1967). One of its 
most interesting activities is its effect on the differentiation of certain 
cell types. In 1971, Friend e^ al_. reported that cells (Friend Leukemic 
Cells) of a cloned line of murine virus-induced erythroleukemia, maintained 
in cell culture, were stimulated to differentiate along the erythroid path­
way by DMSO at concentrations that did not inhibit cell growth. Differen­
tiation was demonstrated by the induction of heme and hemoglobin synthesis. 
Exposure of the cells to DMSO for one hour followed by transfer to DMSO-
free media was sufficient to "trigger" the synthesis of hemoglobin. Con­
trol cells grown in the absence of this agent showed no signs of differ­
entiation. The effect may be reversed by the removal of the DMSO from 
the growth media. Other investigators (Ross et aj_., 1972; Preisler et al., 
1973; Singer et 3%., 1974; Gilmour et ^., 1974) have reported similar 
findings using other cultured leukemia cells. 
The mechanism of action of DMSO in stimulating differentiation of the 
36 
erythroleukemic cells is yet to be understood. Evidence that it affects 
the cell membrane comes from the studies of Weiner et (1972) who 
found the penetrative ability of DMSO might be due to some alteration of 
protein structure as a result of dehydration of the biomembrane. Phospho­
lipids protected the protein from attack by DMSO. That DMSO exerts an 
effect on the regulatory role of lipids for RNA synthesis in mammalian 
cells has been suggested by Lezius and Muller-Lorensen (1974) who found 
that DMSO both stabilizes and stimulates the activity of RNA polymerase A, 
an enzyme stiumlated by neutral phospholipids, by changing the template 
specificity from double stranded in favor of single stranded DMA. Other 
activities of DMSO which may be significant are its ability to stimulate 
microsomal Ca** uptake and to inhibit Na-, K*-dependent adenosine tri­
phosphatase (Burgess et al_., 1969). Friend el^ al_. (1974) also observed 
that DMSO stimulates adenyl cyclase. 
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MATERIALS AND METHODS 
Cell Lines 
Two cell lines were used in this study: 
1. GF9. 6F9 is a mouse white blood cell line deficient in the enzyme, 
hypoxanthine-guanine phosphoribosyl transferase (HGPRT"). GF9 was 
derived by mutagenesis from a population of L5178Y cells (subclone 
43). The L5178Y lymphocytic parent was first isolated from a leu­
kemic mouse by Law, and later grown in vitro by Fischer (1958). GF9 
cells are lymphocytic in appearance, near diploid, and neoplastic. 
These cells are grown in Fischer's medium (Table 2) supplemented with 
10 percent (v/v) heat-inactivated horse serum. They are incubated at 
37°C in a five percent carbon dioxide, 95 percent air atmosphere. 
Grown under these conditions, GF9 cultures have a doubling time of 
10-11 hours (Figure 4). 
2. Intestine 407 (Embryonic Intestine: Human). Intestine 407 was iso­
lated by Henle and Deinhardt (1957) from the jejunum and ileum of a 
two month old human embryo. These cells are grown attached to the 
surface of a culture flask (Falcon Plastics) in Eagle's basal medium 
with Hank's salts (Table 3) supplemented with 15 percent (v/v) heat-
inactivated fetal calf serum. They are incubated at 37° C in an 
atmosphere of five percent carbon dioxide. Under these conditions. 
Intestine 407 has a doubling time of approximately 18 hours. The 
cells are epithelial-like in appearance and are aneuploid. The cell 
line was obtained from the American Type Culture Collection, Rockfield, 
Maryland. 
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Table 2. Components of Fischer's Medium 
Component Mg/Liter 
NaCl 8000.0 
MgClg.GHgO 100.0 
NaHgPOq.GHgO 69.0 
NagHPO^'ZHgO 113.0 
KCl 400.0 
CaCl2'2H20 91.0 
Glucose 1000.0 
L-Arginine 15.0 
L-Cystine 20.0 
L-Glutamine 204.0 
L-Histidine HCl 60.0 
L-Isoleucine 75.0 
L-Leucine 30.0 
L-Lysine HCl 50.0 
L-Methionine 100.0 
L-Phenylalanine 60.0 
L-Threonine 30.0 
L-Tryptophan 10.0 
L-Tyrosine 60.0 
L-Valine 70.0 
L-Asparagine 10.0 
L-Serine 15.0 
Bio tin 0.01 
Choline CI 1.50 
Folic Acid 10.00 
i-Inositol 1.50 
Nicotinamide 0.50 
Ca-pantothenate 0.50 
Pyridoxal HCl 0.50 
Riboflavin 0.50 
Thiamine HCl 1.00 
Phenol Red 5.00 
NaHCOg 1125.00 
Figure 4. Growth curve of GF9 cells in Fischer's Medium 
supplemented with 15 percent horse serum 
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Table 3. Components of Eagle's Basal Medium with Hanks' salts 
Component Mg/Liter 
CaClg 140.00 
KCl 400.00 
KHgPO^ 60.00 
MgClg'GHgO 100.00 
MgSOg'ZHgO 100.00 
NaCl 8000.00 
NaHCOg 350.00 
NagHPO^.ZHgO 60.00 
Glucose 1000.00 
L-Arginine 17.40 
L-Cystine 12.00 
L-Glutamine 292.00 
L-Histidine 8.00 
L-Isoleucine 26.00 
L-Leucine 26.00 
L-Lysine 29.20 
L-Methionine 7.50 
L-Phenyl alanine 16.50 
L-Threonine 24.00 
L-Tryptophane 4.00 
L-Tyrosine 18.00 
Biotin 1.00 
D-Ca-pantothenate 1.00 
Choline Chloride 1.00 
Folic Acid 1.00 
i-Inositol 1.00 
Nicotinamide 1.00 
Pyridoxal HCl 1.00 
Riboflavin 1.00 
Thiamine HCl 1.00 
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Media and Chemicals 
The media and sera used for maintenance of the cell lines were ob­
tained from the Grand Island Biological Supply Company, Grand Island, 
New York. Ethylmethane sulfonate, N-methyl-N-nitro-N-nitrosoguanidine, 
bromodeoxyuridine and isopropyl thioglactoside were obtained from the 
Sigma Chemical Company. Lactose was secured from Mann Research. Di­
methyl sulphoxide was purchased from Fischer Scientific and colcemid was 
obtained from CIBA Pharmaceuticals. 
Cell Counts 
Determinations of cell number were made using a standard cell 
counter (Model ZBI, Coulter Electronics) and by hemacytometer. The cell 
counter is used primarily for the enumeration of cells grown in suspension 
culture. The hemacytometer is used for counting attached cell lines and 
for making viable counts on all cells. 
Viable cell counts involve the use of the vital stain, trypan blue, 
which is mixed 1:1 with cells in growth medium. Nonviable cells incor­
porate the stain and become blue while viable cells do not. 
Treatment With Mutagen 
GF9 cells growing exponentially (10^ cells/ml) were treated with 
various levels of ethylmethane sulfonate (EMS) or N-methyl-N-nitro-N-
nitrosoguanidine (NG) at 37° in Fischer's medium supplemented with 10 
percent horse serum. Cells were exposed to the mutagen for two hours. 
Then the cells were centrifuged, washed once in mutagen-free media and re-
suspended in fresh media without mutagen. The cells were then either 
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cloned immediately in soft agar medium to determine cell survival or were 
grown in suspension for 48 hours in order to allow expression of the mu­
tation before exposure to the selective medium. Survivors of the mutagen 
treatment were measured by cloning 100 cells per 15 x 150 mm test tube in 
soft agar medium at each mutagen concentration. Since each single cell is 
capable of giving rise to a colony of cells, the percentage of cells that 
survived the treatment was determined simply by counting the number of 
colonies obtained. EMS and NG were stored frozen (-20°) at 0.001 g/ml 
in phosphate buffered saline (pH 7.2) and small aliquots were thawed just 
before use. 
Cloning in Soft Agar 
In these experiments GF9 was cloned using the method of Chu and 
Fischer (1968) developed for cloning cells in soft agar gel suspension. 
Three milliliters of Fischer's medium containing 0.2 percent agar (Noble 
agar, Difco Lab.) and 15 percent horse serum were added to 15 x 150 mm 
test tubes. These tubes were maintained at 45® to prevent solidification 
of the agar and then before the addition of cells were removed to a 37° 
water bath. Fifty to a hundred cells in two milliliters of Fischer's 
medium plus 15 percent horse serum were added to each tube to give a final 
concentration of 0.12 percent agar. After gentle mixing of the cells and 
agar, the tubes were placed upright in an ice bath for 2.5 minutes and 
then placed in tissue culture racks for incubation at 37°. To minimize 
breakdown of the agar gel, the racks were placed on foam rubber mats which 
insulated the tubes from vibration during the incubation. Using this pro-
Figure 5. Growth curves of GF9 cells in Fischer's Medium 
containing 15 percent horse serum (control) and 
in Fischer's Medium containing different 
concentrations of lactose and 15 percent dialyzed 
horse serum 
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cedure, GF9 has a cloning efficiency of 80-90 percent. 
Colonies ranging from 0.5-1.0 run in diameter were visible seven to 
eight days later. An average colony contained approximately 10^ viable 
(trypan blue excluding) cells. Colony counts were made using a Quebec 
darkfield colony counter (American Optical Company). Mature colonies 
were isolated by suction with a pasteur pipette and dispersed in 0.5 ml 
medium in a test tube where the cells resumed growth in suspension culture. 
Selection For Lactose (lac^) Mutants 
By formulation Fischer's medium (Table 2) contains 0.0055 M 
(Ig/liter) glucose. In the selective medium, all glucose is replaced by 
0.011 M (3.76 g/liter) lactose. Lactose is a disaccharide consisting of 
one molecule of glucose and one molecule of galactose. On hydrolysis 
these components are released in equal quantities. Thus, to insure that 
the original glucose concentration may be restored, twice as much lactose 
is used in the selective medium. 
The complete selective medium contains Fischer's medium modified by 
lactose plus 15 percent dialyzed horse serum. In order to remove glucose 
the horse serum was dialyzed for 20 hours against three volume changes of 
0.85 percent saline and tested for the presence of glucose by the "gluco-
stat" (Worthington Biochemicals), an enzymatic reaction for the detection 
of glucose, and was found to be free of this sugar. 
The parental GF9 cell is unable to utilize lactose as a carbon source 
(Figure 5). Thus, only mutant cells would be expected to survive in se­
lective medium where lactose is provided as the sole carbon source. Se­
lection for lactose utilizing (lac*) mutants was performed by plating 
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4.0 X 10^ mutagen treated viable cells per test tube in the selective 
medium containing soft agar. Variant colonies were visible three weeks 
after plating and were isolated at that time in 0.5 ml selective medium 
or 0.5 ml nonselective medium in order to obtain suspension cultures. 
Colonies isolated in nonselective medium (Fischer's medium containing 
glucose plus 15 percent nondialyzed horse serum) were tested on the 
selective medium when a sufficient volume of cells were obtained. 
Enzyme Induction Experiments 
Two agents were utilized as potential inducers of the lactase en­
zyme in the mammalian cell lines: lactose and isopropyl B-D-thiogalacto-
pyranoside (IPTG). Both of these compounds are inducers of beta galacto-
sidase in bacteria (Jacob and Monod, 1961). The induction procedure was 
as follows: 
GF9 and mutant colonies 
5 The cells were allowed to grow to a density of 5.0 x 10 cells/ml 
in the nonselective medium. They were then centrifuged, washed once in 
sugar-free medium and resuspended in Fischer's medium containing various 
levels of lactose and 15 percent dialyzed horse serum or in the same me­
dium containing different levels of IPTG plus 15 percent dialyzed horse 
serum. The cells were incubated in this medium for a period of 12 hours 
(the cellular glucose is depleted in these cells in approximately six 
hours). Thereafter, the cells were harvested and assayed for lactase 
activity. 
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Intestine 407 
The cells were allowed to grow until a confluent monolayer of cells 
was obtained. The medium was then removed and the monolayer washed once 
with sugar-free medium. Eagle's basal medium without sugar plus 15 per­
cent dialyzed fetal calf serum was then added to the cells and the cultures 
were incubated in this medium for 12 hours to insure depletion of glucose 
in the cells. At the end of this incubation period, different concen­
trations of lactose or IPTG were added to the cells and incubation con­
tinued for another 12 hours. Thereafter, the cells were harvested and 
assayed for lactase activity. 
Treatment of Cells with BUDR and DMSO 
BUDR and DMSO were added to the growth medium in the concentrations 
cited in the Results section. For the dose response curves, replicate 
cultures were incubated at cell concentrations of 5.0 x 10^ cells/ml in 
medium with these chemicals. Viable cell counts were made daily. 
The concentration of BUDR and DMSO which did not appreciably affect 
cell growth was then used with medium containing lactose in an attempt 
to induce lactase production and subsequent growth of GF9 cells in me­
dium containing lactose as the sole carbon source. 
Determination of Enzyme Activity 
Lactase activity was assayed by a modification of the method de­
scribed by Dahlqvist (1964). Cells growing exponentially (5.0-6.0 x 10^ 
cells/ml) were harvested by centrifugation, washed once in a balanced 
salt solution and resuspended In distilled water at 4.0-7.0 x 10^ 
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cells/ml. The cells were then lysed by rapid freezing and thawing until 
a homogenous extract was obtained (four to five freeze-thaw cycles). 
This preparation was then centrifuged at 20,000 x g for 10 minutes and 
the supernatant used for the assay. The assay procedure was carried out 
in the following manner: one milliliter of the supernatant was mixed 
with 0.1 ml of the substrate (0.056 M lactose) in a small test tube and 
incubated in a 37° water bath for one hour. The enzymatic reaction was 
stopped by immersing the tube in boiling water for two minutes. For de­
termination of the amount of glucose present, 0.5 ml of the above reaction 
mixture was mixed with 3 ml of tris glucose oxidase reagent (Worthington 
Biochemicals) and incubated at 37° for one hour. The light absorption 
was then measured in a Beckman DU-2 spectrophotometer at 420 mu using one 
centimeter cuvettes. 
An extract prepared from fetal mice small intestine which is known to 
contain lactase activity was used as a control for the assay. 
Establishment of a Primary Cell Line from Fetal Mouse Intestine 
Pregnant mice (Mus musculus) were obtained from Dr. Willard Hollander, 
Genetics Laboratory, Iowa State University. On the 18th day of gestation, 
the mice were sacrificed and the fetuses were removed. The entire small 
intestine was removed from each fetus and washed several times in Hank's 
balanced salt solution containing 20,000 units of penicillin and 20,000 
units of streptomycin (GIBCO). The intestinal tissue was then cut into 
small pieces and incubated in a 0.25 percent trypsin-EDTA (0.5 g trypsin: 
0.2 g EDTA/liter) solution for 15 minutes to disperse the tissue. The 
trypsin activity was stopped by the addition of an equal volume of horse 
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serum. The cells were then filtered through a double layer of cheese 
cloth to remove chunks of tissue that had not been dispersed. The single 
cells were centrifuged at 1500 r.p.m. for 10 minutes and resuspended in 
Eagle's basal medium supplemented with 15 percent horse serum. The cells 
were placed in 25 cm culture flasks (Falcon Plastics) at a concentration 
of 10® eel Is/flask and incubated at 37°. 
Infection of Fetal Mouse Small Intestinal Cells with SV-40 Virus 
The SV-40 virus was isolated from baboon kidney cells grown in cul­
ture. It was obtained from the Southwest Foundation for Research and 
fi 3 Education, San Antonio, Texas. The titer of the virus was 10 * TCID^q 
(tissue culture infectious dose for 50 percent response) per 0.1 ml. The 
50 percent infectious dose is the smallest volume of virus capable of pro­
ducing a response in 50 percent of the susceptible cells. 
Flasks of cells were exposed to 0.5 and 0.25 ml of virus for periods 
of four or 24 hours. The cultures were then washed and fresh medium was 
added; the medium was changed daily. 
Chromosome Analysis 
The mitotic chromosomes of GF9 and variant colonies were prepared in 
the following way: cells growing exponentially were arrested in meta-
phase by adding colcemid at a final concentration of 0.2 ug/ml to the 
culture medium. The cells were incubated in the presence of this drug 
for a period of four to six hours at 37°. Following the incubation per­
iod the cells were pelleted by centrifugation at 1200 r.p.m. for six 
minutes. The pellet was resuspended in 3 ml hypotonic KCl (0.75 M). 
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This agent induces swelling and was left on the cells for 8 minutes. The 
treated cells were then centrifuged for 6 minutes at 600 r.p.m. All but 
0.5 ml of the supernatant was removed by aspiration and the cells were 
gently resuspended in the remaining supernatant and fixed in Carnoy's fix 
ative (one part glacial acetic acid:three parts absolute methanol) at 
4°C for 10 minutes. The cells were centrifuged and all of the superna­
tant was removed by aspiration. The pellet was resuspended in Carnoy's 
fixative and fixed for another 10 minute period at 4°C. At the end of 
this fixation period the cells were collected by centrifugation and all 
but 0.25 ml of the supernatant was removed by aspiration. The cells were 
resuspended in the residue by gentle agitation with a pasteur pipette. 
Two to three drops of the cell suspension was then placed on a slide 
(stored in cold distilled water) and quickly blown to spread as widely as 
possible. The slide was allowed to air dry for 15 minutes and was then 
stained with aceto orcein stain (orcein obtained from Gurr, Biomedical 
Specialities). 
52 
RESULTS 
Sensitivity of GF9 Cells to EMS and NG 
The survival of GF9 cells after treatment with various concentra­
tions of the mutagens, EMS and NG, is shown in Figure 6. Both curves 
are multihit curves (Kao and Puck, 1969, 1971) which is an indication 
that some threshold process must be exceeded before cell killing occurs 
in linear proportion to the dose of mutagen. In mutagenesis experiments, 
that concentration of mutagen which gave a cell survival of approximately 
20 percent was used. For EMS this was 1.3 x 10"^ M and for NG, 10'® M. 
Similar values were obtained in EMS and NG survival experiments with the 
related cell strain L5178Y (Summers, 1973). 
Induction and Isolation of Lactose (lac*) Variants 
Tables 4 and 5 summarize the results of mutagenesis experiments with 
5 EMS and NG respectively. An average of 9.69 variant colonies per 10 
surviving cells was obtained when the parental cells were treated with 
EMS and plated in selective medium in which lactose was the sole carbon 
source provided. Treatment with NG yielded an average of 1.35 variants 
per 10^ surviving cells. Colonies recovered from the selective medium 
were either subcultured directly in liquid selective medium (to test 
their ability to utilize lactose in suspension culture) or, they were 
first isolated in nonselective medium and then tested in medium contain­
ing lactose and 15 percent dialyzed horse serum. As the last column in 
Tables 4 and 5 indicates, none of the colonies tested proved to be able 
to utilize lactose in suspension culture. It would be expected that true 
Figure 6. Survival of 6F9 cells after treatment with various 
concentrations of EMS for 2 hours (A) or NG for 2 
hours (B). For each point 16 replicate tubes 
containing 100 cells/tube is plotted. 
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Table 4. Summary of EMS mutagenesis experiments^ 
Number Percent of Number of Frequency of Number of 
Viable Cells Plated Cells Variant Variant Colonies Colonies 
Plated Surviving^ Colonies in Population Tested Able 
Recovered of Surviving to Utilize 
Cells Lactose" 
(x 10-S) 
8.56 X 10^ 2.70 121 5.26 0 
14.00 X 10^ 1.40 452 6.36 0 
6.27 X 10^ 2.60 182 11.37 0 
6.64 X 10^ 3.00 304 11.60 0 
7.64 X 10^ 3.37 218 8.48 0 
6.64 X 10^ 5.35 278 7.94 0 
7.68 X 10^ 3.46 292 11.00 0 
13.40 X 10^ 2.98 357 8.94 0 
8.00 X 10^ 3.00 227 9.45 0 
7.50 X 10^ 2.65 187 9.44 0 
6.40 X 10^ 3.15 205 10.20 0 
10.00 X 10^ 3.00 327 10.91 0 
10.50 X 10^ 2.53 397 15.10 0 
113.23 X lO' - 3547 - 0 
Average values: 3.01 - 9.69 X lO'S -
Cumulative Control®: 
1.99 X 10® 8.30 2.00 .012 0 
®EMS concentration + 1.3 x 10"^ M. 
^Cells were plated in nonselective medium supplemented with 15 per­
cent dialyzed horse serum. 
^Cells were plated in selective medium supplemented with 15 percent 
dialyzed horse serum. 
^In each experiment 100 colonies were tested for growth in liquid 
selective medium. 
®Cells were not exposed to mutagen but were plated in selective 
medium. 
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Table 5. Summary of NG mutagenesis experiments ^ 
Number Percent of Number of Frequency of Number of 
Viable Cells Plated Cells Variant Variant Colonies Colonies 
Plated Surviving" Colonies in Population of Tested Able 
Recovered Surviving Cells to Utilize 
(x lO'S) Lactose^ 
8.0 X 10^ 2.93 24 1.00 0 
7.6 X 10^ 2.50 26 1.30 0 
6.0 X 10? 3.18 24 1.26 0 
7.36 X 10? 2.75 21 1.03 0 
4.84 X 10? 2.62 14 1.16 0 
7.68 X 10? 2.75 51 2.37 0 
41.48 X 10? - 160 - 0 
Average Values: 2.78 - 1.35 X lO'S -
Cumulative Control®: 
1.99 X 10® 8.30 2.0 .012 -
®N6 concentration = 10"^ M. 
^Cells were plated in nonselective medium supplemented with 15 per­
cent dialyzed horse serum. 
^Cells were plated in selective medium supplemented with 15 percent 
dialyzed horse serum. 
^All variant colonies in each experiment were tested for growth in 
liquid selective medium. 
®Cells were not exposed to mutagen, but were plated in selective 
medium. 
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lactose-utilizing mutants would grow in suspension culture as well as 
agar culture when lactose is the only carbon source provided. Therefore, 
the colonies are referred to as "lactose selection variants". 
Control experiments were carried out to determine whether these 
variants occurred spontaneously or if they arose as the result of muta­
genic action. Untreated GF9 cells were cloned in selective medium at a 
concentration of 4.0 x 10^ viable cells per tube. The results of these 
trials are given in Table 6. In these tests two colonies were recovered 
p 
per 1.99 x 10 viable cells plated. However, this number is insignificant 
when compared with the number of colonies obtained after treatment with 
the mutagens, EMS and NG. A total of 3547 colonies were recovered per 
1.13 X 10^ cells plated following EMS treatment (Table 4); and 160 colo-
Q 
nies per 4.14 x 10 cells plated were obtained after treatment with NG 
(Table 5). 
Studies of the Origin of "Lactose Selection Variants" 
Since the mutagen-induced variants did not prove to have the pheno-
type expected to be associated with lac* mutants, i_.e_., the ability to 
utilize lactose in suspension culture, further attempts were made to 
characterize the events causing the appearance of these colonies. Four 
alternative situations were explored. 
The first alternative 
The first situation considered was that the "lactose selection 
variants" might have resulted from growth on trace amounts of residual 
glucose in the selective medium. This possibility was examined by 
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Table 6. Experiments to detect spontaneous mutational events which 
yielded "lactose selection variants" 
Number 
Viable Cells 
Plated 
Percent of 
Plated Cells 
Surviving in 
Nonselective 
Medium^ 
Number of 
Variant Colonies 
Recovered In 
Selective 
Medium b 
Frequency of 
Variant Colonies 
in Population of 
Surviving Cells 
(xlQ-S) 
2.0 X 10^ 6.88 0.0 0.000 
4.9 X 10^ 8.73 0.0 0.000 
6.0 X 10^ 7.48 2.0 .012 
7.0 X 10? 10.03 0.0 0.000 
19.9 X 10? 2.0 
Average Values: 8.28 - .003 x 10"^ 
^Fischer's Medium plus 15 percent dialyzed horse serum. 
'^Fischer's Medium containing lactose plus 15 percent dialyzed 
horse serum. 
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conducting sugar analyses of all components of the selective medium. 
Since the parental cells can utilize galactose as well as glucose as a 
carbon source, the selective medium components were tested for both glu­
cose and galactose using the "glucostat" and the "galactostat" (Worthing-
ton Biochemicals). These are prepared reagents for the quantitative 
and colorimetric determination of glucose and galactose respectively. 
The "glucostat" contains glucose oxidase; and the "galactostat" contains 
galactose oxidase. For a complete explanation of these tests and the 
assay procedure, the reader is referred to the Worthington Enzyme Manual 
(Worthington Biochemical Corporation, 1972). 
The standard curves for the "glucostat" and the "galactostat" are 
given in Figures 7 and 8 respectively. The average optical density 
(O.D.) reading for the "glucostat" reagent blank was 0.015. It was 
assumed that any O.D. value greater than or equal to 0.015 would be sig­
nificant. A 0.015 O.D. value gives a glucose concentration of 10 mg/100 
ml or 5.0 x 10"* M. Therefore, if glucose were present in a sample at a 
concentration greater than or equal to 5.0 x 10"* M it would have been 
detected. 
The average O.D. reading for the reagent blank in the "galactostat" 
was 0.045. It was supposed that any O.D. value greater than or equal to 
0.045 would be significant. This absorbance at 425 mu gives a galactose 
-4 
concentration of 15 ug/0.5 ml or 2.0 x 10 M. If components of the 
selective medium had contained galactose at an amount greater than or 
equal to 2.0 x 10"* M, it would have been ascertained. 
The results of these tests are given in Table 7. It was described 
Figure 7. Glucose standard curve for the "glucostat" reagent 
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Figure 8. Galactose standard curve for the "galactostat" reagent 
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Table 7. Tests for residual glucose and galactose in selective medium 
components 
Component 
All chemicals in 
Fischer's medium 
excluding glucose 
Noble Agar (0.12%) 
Lactose: 
0.011 M 
0.044 M 
0.500 M 
1.000 M 
Dialyzed horse 
serum 
Controls: 
Fischer's Medium 
(Standard formula*) 
1.0 percent 
Galactose solution 
Amount of Glucose 
(Moles/Liter) 
< 5.0 X o
 1 
< 5.0 X 10-4 
< 5.0 X 10-4 
< 2.0 X 10-3 
< 2.5 X 10-2 
< 5.0 X 10-2 
< 5.0 X 10-4 
5.5 X 10-3 
Amount of Galactose 
(Moles/Liter) 
< 2.0 X 10 
< 2.0 X 10 
< 2.0 X 10 
< 4.0 X 10 
< 1.0 X 10 
< 2.0 X 10' 
< 2.0 X 10 
2.8 X 10-2 
*See Table 4. 
^Interpolated values for amount of glucose in sample. See text for 
explanation. 
^Interpolated values for amount of galactose in sample. See text 
for explanation. 
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above that the "glucostat" was insensitive to levels of glucose less than 
5.0 X 10"* M; and the "galactostat" insensitive to levels of galactose 
less than 2 x 10"* M. Hence, it is possible that each component tested 
was contaminated with one of these sugars at an amount lower than the 
level of detection of these assays. Accordingly, these values were used 
in Table 7 to indicate limits for the amount of glucose or galactose that 
might have been present in each selective medium component. However, 
significant O.D. readings, !.•§.•» ^.D. readings above that of the control 
blank, were not obtained for any of the components tested using the pre­
pared reagents. 
Fischer's medium lacking glucose was specially prepared for use in 
this study by the Grand Island Biological Supply Company, Grand Island, 
New York. This medium consists of only salts, amino acids, and vitamins. 
Therefore it is very unlikely that it contained any sugar. It is also 
equally unlikely that the Noble Agar contained any free sugar (personal 
communication, Difco Lab. technical advisor). 
The lactose which was used in the selective medium at a concentration 
of 0.011 M was checked for glucose and galactose impurities at concentra­
tions of 0.044 M, 0.5 M, and 1.0 M. These amounts were 4, 50, and 100 
times the normal amount used respectively. If 0.011 M lactose contains 
less than 5.0 x 10'* M glucose or less than 2 x 10"* M galactose, in­
creasing the amount of lactose would increase the probability of the sugar 
being detected. For example, if glucose were present at less than 5.0 x 
10"* M in a 0.011 M lactose solution, the amount in a 0.044 M solution 
-3 
would have been less than 2.0 x 10" M; in a 0.5 M solution less than 
2.5 X 10" M; and in a 1.0 M solution less than 5.0 x 10" M. These 
values would be well within the detectable range of the "glucostat". The 
same argument holds for galactose (Table 7). Positive results were not 
obtained when the above concentrations of lactose were tested. Therefore, 
the lactose used in the selective medium did not contain glucose or galac­
tose impurities. 
Definite conclusions regarding the presence or absence of trace 
amounts of glucose or galactose in the dialyzed horse serum could not be 
drawn using the above chemical tests. However, dialysis for 20 hours 
against three volume changes of 0.85 percent saline should have been suf­
ficient to remove all sugar. Furthermore, data presented in Figures 9 and 
10 and in Table 8 show that if the dialyzed horse serum did contain trace 
amounts of glucose or galactose, these amounts were evidently inadequate 
to support cell growth in the absence of sufficient quantities of added, 
metabolizable sugar. Therefore the dialyzed horse serum was not responsi­
ble for the appearance of colonies in the selective medium. 
In relation to the first possibility, that the appearance of the 
"lactose selection variants" was due to growth on residual glucose or 
galactose in the selective medium, it was assumed that the colonies might 
have been mutagen-induced, stable variants capable of growing in medium 
containing very low levels of glucose or galactose not detectable by the 
tests described above. Since glucose is the standard sugar in culture 
medium, this theory was investigated by performing growth experiments on 
parental cells in medium containing different concentrations of glucose 
and dialyzed horse serum. Growth curves of untreated GF9 cells on various 
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levels of added glucose are shown in Figure 9. These growth studies 
were carried out on the assumption that the dialyzed horse serum was 
probably free of glucose. However, as indicated above, the serum might 
possibly have contained some glucose (less than 5.0 x 10"* M). Thus the 
glucose concentrations stated in Figure 9 may need to be adjusted. Note 
that the lowest concentration of added glucose at which there is no 
appreciable growth is 5.5 x 10"^ M. If the isolated colonies were indeed 
stable variants capable of growing in low levels of glucose, they should 
have been able to grow at this concentration of glucose which would not 
support growth of the parental cells. 
Twenty variant colonies were tested to determine if they could pro­
liferate in medium containing this amount of glucose. Typical growth 
curves for 20 of the variants are shown in Figure 10. This level of glu­
cose did not support growth of the "lactose selection variants". There­
fore, it is not reasonable to conclude that these were stable variants 
that appeared in the selective medium because of a new, mutagen-induced 
capability for growth on low levels of glucose. 
The second alternative 
The second alternative tested was that the variants might have 
resulted from cross-feeding between cells cloned as clumps rather than as 
individual cells. Cross-feeding is an event in which some cells of a 
group supply nutrients that promote the growth and formation of colonies 
by surrounding cells. In this case, cross-feeding would mean that one or 
two clumped cells would have been able to provide enough carbon for cell 
Figure 9. Growth curves of GF9 in Fischer's Medium 
containing different concentrations of 
glucose plus 15 percent dialyzed horse serum. 
RHS, nondialyzed horse serum; DHS, dialyzed 
horse serum; Glu., glucose. 
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division and maintenance of surrounding cells. This possibility was ex­
amined by cloning mutagen-treated cells in Fischer's medium lacking an 
added carbon source and containing 15 percent dialyzed horse serum at a 
5 
concentration of 4.0 x 10 cells per tube. If cross-feeding were the 
causative factor in the appearance of "lactose selection variants", the 
absence of lactose should not prevent the appearance of variant colonies. 
Table 8 gives the results of these experiments. Variant colonies were 
not obtained. These findings suggest that the mutagens did not induce an 
artificial cell clumping which caused cross-feeding of cells and false 
appearance of colonies. 
The third alternative 
The third alternative was that the variant colonies could utilize 
lactose only in agar culture as opposed to lactose-containing suspension 
medium. To determine if this was true, 20 clones were isolated, dis­
persed in 0.5 ml selective medium and immediately recloned in selective 
medium at a concentration of 10^ cells per tube. A total of 4.0 x 10^ 
cells were cloned from each variant colony. A GF9 parental clone was 
isolated, dispersed in 0.5 ml nonselective medium and recloned at 100 
cells per tube. Four tubes were cloned. 
GF9 yielded an average of 20.25 colonies per 100 cells plated. Al­
though this cloning efficiency was considerably lower than normal (80-90 
percent), it indicated that the procedure was practicable. Of the 20 vari­
ants recloned, only one gave a positive result. This one variant yielded 
one colony or an average of 0.25 colonies per 10^ cells plated. This sub­
clone was reisolated from the cloning medium and dispersed in 0.5 ml 
73 
Table 8. Cloning experiments designed to detect cross-feeding 
in mutagen treated cells 
Number 
Viable Cells 
Plated 
Percent of 
Plated Cells 
Surviving in 
Nonselective 
Medium^ 
Number of 
Variant Colonies 
Recovered in 
Medium Lacking 
Carbon sourceb 
Frequency of 
Variant Colonies 
in Population of 
Surviving Cells 
(x 10-5) 
6.87 X 10? 3.30 0.0 0.0 
7.64 X 10? 4.20 0.0 0.0 
7.00 X 10? 3.72 0.0 0.0 
8.00 X 10^ 2.70 0.0 0.0 
29.5 X 10? - - -
Average values: 3.48 - -
^Fischer's Medium plus 15 percent dialyzed horse serum. 
^Fischer's Medium minus sugar plus 15 percent dialyzed horse serum. 
selective medium. It contained approximately 3.5 x 10^ viable cells, 
which were immediately recloned again in selective medium at 10^ cells 
per tube. A total of 3.0 x 10^ cells were plated. No colonies were ob­
tained from this second recloning. 
The results of these recloning experiments indicate that the colonies 
were not variants fully capable of utilizing lactose only in agar culture. 
The fourth alternative 
The fourth and final alternative considered was that the "lactose 
selection variants" might have been the result of an unstable "lac* con­
dition", i.e., some of the mutagen-treated cells might have been able to 
utilize lactose for a brief period because of a temporary production of 
lactase. If it were assumed that the lactase enzyme in mammalian cells 
is regulated by a repressor substance, such an event could have occurred 
as the result of: (1) an unstable alteration in the repressor gene; 
(2) a loss of the chromosome bearing the repressor. 
An alteration in the gene that produces the repressor molecule could 
have inhibited the production of the repressor, or caused the synthesis 
of a nonfunctional repressor, a repressor incapable of binding to DNA. 
The occurrence of either of these events would permit the synthesis of 
lactase. 
Chromosomal loss could have caused the temporary production of lac­
tase only if the repressor and structural genes were not on the same 
chromosome. If this were true, a loss of chromosomes from the cells 
could mean that the chromosome bearing the repressor gene had been lost. 
These cells would then be eventually selected against, even in lactose 
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medium, because of the loss of other vital chromosomal functions. 
Neither of the proposed explanations to account for the unstable 
"lac^ condition" could be tested experimentally. However, the second 
proposal was investigated by checking the variants for changes in chro­
mosome number. Ten variants, numbered LAI-LAI0, were isolated and their 
karyotypes analyzed. Analyses were made at one and two weeks after iso­
lation from the selective medium. At that time variants LAI-LAS had 
gone through approximately 20 generations, LA6-LA10 about 25-37 gener­
ations. 
The modal chromosome number for GF9 is 40. Chromosome distribution 
patterns of GF9 and the variants are given in Figures 11, 12, and 13. 
Chromosome patterns for LA4 and LA8 are not included; the preparations 
were lost. Significant differences (determined statistically using the 
;t test) were found between the mean chromosome number of the parental 
cells and variants LAI, LA7, and LA9. Mean chromosome numbers for these 
variants are 38.8, 38.1, and 36.1 respectively. Also there is an obvious 
difference between the distribution pattern of GF9 and variants LA3 and 
LA7. The wider distribution pattern in these variant clones is a clear 
illustration that there are a larger number of cells with fewer chromo­
somes. However, these findings alone are not sufficient to conclude that 
the condition described above actually did occur, but they do suggest that 
chromosomal instability may have been a means whereby a temporary pro­
duction of lactase could have occurred. 
Assuming that the variants may have been the result of a temporary 
production of lactase, attempts were made to detect lactase activity in 
Figure 12. Histiograms of chromosome per cell against 
number of cells. For 6F9 and each variant 
100 cells were counted. The diploid number 
(2n) of the mouse is 40. 
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single colonies immediately after they became visible in the cloning 
medium. The variant clones contain approximately 5.0 x 10^ cells. These 
are too few cells to use the lactase assay procedure described in the 
Materials and Methods section. Therefore, another detection procedure was 
used. 
0-nitrophenyl-B-galactoside (ONPG) is a synthetic beta-galactoside 
and a substrate of beta-galactosidases in mammals (see Literature Review) 
and in bacteria. When this compound is hydrolyzed by the enzyme a char­
acteristic yellow color is produced. It was reasoned that if the clones 
contained lactase and they were placed in a solution of ONPG, the syn­
thetic substrate would be hydrolyzed producing an observable yellow color. 
Variant colonies were isolated from the selective cloning medium, 
washed once with a balanced salt solution, dispersed in 0.5 ml of a 2.0 mM 
solution of ONPG in a small test tube, and incubated for 1-3 hours at 
room temperature. Separate incubations were also made at 37° C for the 
same time period. At the conclusion of the incubation period, the tubes 
were observed for a color change. Fifty colonies were tested in this 
manner; a positive reaction was not observed for any of the clones. 
Growth Characteristics of Variant Colonies 
Growth curves for five of the variants are shown in Figure 14. These 
curves are typical of the more than 50 colonies tested. The "lactose 
selection variants" have an average doubling time of 16 to 24 hours which 
is longer than that of GF9 (10 to 11 hours). 
Cloning efficiencies for 10 of the variants are shown in Table 9. 
These are the variants that were analyzed for a loss of chromosomes. 
Figure 14. Growth curves for GF9 and five of the variant 
colonies in Fischer's Medium plus 15 percent 
horse serum 
3 4 
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85 
Table 9. Cloning efficiencies of "lactose selection variants"® 
Variant Percent Cloning 
Efficiency 
LA 1 77.56 
LA 2 88.00 
LA 3 86.62 
LA 4 80.50 
LA 5 85.50 
LA 6 82.75 
LA 7 87.50 
LA 8 84.00 
LA 9 81.25 
LA 10 85.50 
GF 9 88.92 
Variants were cloned in Fischer's Medium supplemented with 
15 percent horse serum at a concentration of 100 cells/tube. 
Sixteen replicate tubes were plated for each variant. LA 1-
LA 5 were cloned at approximately 20 generations; LA 6-LA 10 at 
approximately 25-37. 
8 6  
Cloning efficiencies for these clones ranged from 77.56-87.50 percent. 
The parental cells have a cloning efficiency of 80-90 percent. 
Effect of BUDR and DMSO on GF9 Cells 
The dose response curves for BUDR and DMSO are shown in Figures 15 
and 16 respectively. Cells grown in medium containing 3 ug/ml BUDR and 
three percent DMSO multiplied at approximately the same rate as those of 
the control cultures. In cultures treated with these agents no morpho­
logical changes were observed. In separate experiments, BUDR (3 ug/ml) 
and DMSO (three percent) were added to selective medium containing dif­
ferent concentrations of lactose in an attempt to induce the synthesis 
of lactase. The results of these tests are given in Figures 17 and 18. 
Viable cell counts were made daily. No cell growth was observed; this 
indicated the absence of lactase activity. The cultures were maintained 
until no viable cells were noted. This eliminated the possibility that 
only a small subpopulation of cells may have been capable of growing in 
medium containing BUDR and lactose and in medium containing DMSO and 
lactose. 
Induction Experiments With Intestine 407, GF9 and Variants 
Embryonic Intestine 407 is a small intestinal epithelial cell line 
and therefore must certainly retain the genetic potential necessary for 
the production of lactase. However, this cell line will not grow in me­
dium containing lactose and dialyzed horse serum, indicating the absence 
of any functional lactase activity. Since this cell line is naturally 
expected to have lactase activity, it appears that the enzyme has been 
Figure 15. Dose response curves of GF9 cells in Fischer's 
Medium containing different concentrations of 
BUDR and 15 percent horse serum 
Number Cells/ml 
8 8  
Figure 16. Dose response curves of GF9 cells in Fischer's 
Medium containing different concentrations of 
DMSO and 15 percent horse serum 
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Figure 17. Growth curves of GF9 cells in Fischer's Medium 
containing glucose, 3 ug/ml BUDR and 15 percent 
dialyzed horse serum; and in Fischer's Medium 
containing lactose, 3 ug/ml BUDR and 15 percent 
dialyzed horse serum 
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Figure 18. Growth curves of GF9 cells in Fischer's Medium 
containing glucose, 3 percent DMSO, and 15 
percent dialyzed horse serum; and in Fischer's 
Medium containing different concentrations of 
lactose, 3 percent DMSO and 15 percent dialyzed 
horse serum 
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"turned off" or perhaps it was never "turned on" (this cell line was es­
tablished from a two month old embryo; lactase is not present in the hu­
man fetus until around the middle of gestation). 
Attempts were made to induce the lactase enzyme in Intestine 407 
using lactose and isopropyl thiogalactoside. These agents are known in­
ducers of the beta-galactosidase enzyme in Escherichia coli (Jacob and 
Monod, 1961). The results are given in Table 10. Lactase was not induced 
in 407 with these compounds. 
The same agents were used in induction experiments with GF9 and some 
of the "lactose selection variants" (Table 10). The results again were 
negative. 
A Fetal Mouse Small Intestinal Cell Line 
All attempts to establish a line of small intestinal epithelial cells 
from fetal mice were futile. The cultures consisted of two types of cells; 
fibroblast and epithelial cells. After approximately 2-3 days in culture, 
epithelial cells were no longer present, fibroblasts were maintained in 
culture for several weeks but neve? grew to give a confluent monolayer of 
cells. Attempts were made to select for epithelial cells initially by 
placing the cells directly in medium containing lactose and dialyzed horse 
serum. In this medium the cells did not attach to the surface of the 
culture flask and did not grow. Thus, the cells were placed directly in 
medium containing glucose and regular horse serum and allowed to attach 
to the culture flask. Three to four days later this medium was removed 
and medium containing lactose and dialyzed horse serum was added. The 
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Table 10. Induction experiments 
Cells Used Inducer Concentration Length of Lactase 
of Inducer Induction Activity 
Intestine 407 None - - 0.0 
Lactose .OHM 12 hrs. 0.0 
.022M 12 hrs. 0.0 
IPTG 10"^M 12 hrs. 0.0 
lO'^M 12 hrs. 0.0 
GF 9 None - - 0.0 
Lactose .OHM 6 hrs. 0.0 
.022M 6 hrs. 0.0 
IPTG lOr^M 6 hrs. 0.0 
lOr^M 6 hrs. 0.0 
Variant ^ None - - 0.0 
Colonies 
Lactose .OHM 6 hrs. 0.0 
.022M 6 hrs. 0.0 
IPTG lO'^M 6 hrs. 0.0 
lO'^M 6 hrs. 0.0 
Control for Assay: 
Extract from 
Mouse 
Intestine 
3.8 
^Expressed as Moles disaccharide hydrolyzed/min. 
^A total of 20 variant colonies were tested separately. 
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cells did not grow in this medium and became detached from the surface of 
the flask. This indicated that these cells were not capable of utilizing 
lactose and that there was no lactase present. It appeared that these 
cells are capable of undergoing only a finite number of divisions in vitro. 
Assuming this to be true, attempts were made to increase the proliferation 
of these cells by transforming them with SV-40 virus. This also proved 
to be unsuccessful. Increased numbers of fibroblasts were obtained but 
epithelial cells were still only present for 1-3 days in culture. These 
cultures were unable to utilize lactose. Table 11 outlines the procedures 
used in the attempt to establish a line of epithelial cells from fetal 
mouse intestine in culture and gives the results of each variation in 
technique. 
Table 11. Outline of procedures used to establish a small intestinal epithelial cell line from 
fetal mi ce 
Procedures Results 
I. Isolation of small intestinal tissue from 
fetal mice and dispersion of the tissue 
with trypsin 
II. Establishment of cultures 
A suspension of single cells, 
A. Cells plated directly in selective 
medium.3 
Cells did not attach to the surface of the 
culture flask. 
B. Cells plated directly in nonselective 
medium.b 
These cultures were treated in two ways: 
1. Medium removed. Cells washed 
once with a balanced salt 
solution and selective medium 
added. 
2. Cells remained on nonselective 
medium. 
Cells became attached to the culture flask 
surface. Cultures consisted of two cell 
types, morphologically similar to fibro­
blasts and epithelial cells. 
Cells became detached from the surface of 
the culture flask. 
A confluent monolayer of cells was not 
obtained. 
^Selective medium. Eagle's basal medium with Hank's salts containing 0.011 lactose and 
15 percent dialyzed horse serum. 
^Nonselective medium. Eagle's basal medium with Hank's salts containing 0.0055M glucose 
and 15 percent dialyzed horse serum. 
Table 11 continued 
Procedures Results 
C. Cells inoculated with 0.5 and 
0.25 ml SV-40 virus in nonselective 
medium^ 
Epithelial-like cells were present for 
only 1-3 days in culture. Fibroblasts-like 
cells were present for approximately two 
weeks. 
Cells became attached to surface of culture 
flask. 
These cultures were treated in two 
ways: 
1. Medium removed. Cells washed 
once with a balanced salt 
solution and selective medium 
added. 
2. Medium removed. Cells washed 
once with a balanced salt 
solution and nonselective 
medium added. 
Cells became detached from the surface of 
the culture flask. 
Confluent monolayer of cells obtained. 
Number fibroblast-!ike cells increased 
greatly. No increase in the number of 
epithelial-like cells was observed. 
^Titer of virus = lO^'^CIDgg/.l ml. 
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DISCUSSION 
The objective of this study was to establish a mammalian cell line, 
in culture, that actively produced the lactase enzyme. It was hoped that 
such a cell system would provide a means whereby the biochemical proper­
ties and the genetic regulation of this intestinal disaccharidase could be 
thoroughly investigated. Three approaches were used to accomplish this 
objective: 
1. Attempts were made to induce lactase activity in Intestine 407, a 
previously established small intestinal epithelial cell line, and 
in GF9, an established white blood cell line, by using lactose and 
isopropyl-thiogalactoside. 
2. Attempts were made to establish a small intestinal epithelial cell 
line from fetal mice in culture. 
3. Attempts were made to reverse natural lactase differentiation in 
GF9 cells by exposing these cells to mutagens and agents known to 
affect differentiation in other cell types. 
Lactase activity was not induced in Intestine 407 and GF9 cells 
using lactose and isopropyl-thiogalactoside, known inducers of beta-galac-
tosidase in bacterial systems (Jacob and Monod, 1961). Although human 
and animal in vivo studies suggest that lactase is not inducible by lac­
tose, this conclusion cannot be drawn from nf\y experiments because it is 
possible that the system for transport of lactose into GF9 cells is de­
fective. 
When the beta-galactosidase gene is activated in Escherichia coli. 
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another gene is also induced. This gene codes for the production of a 
molecule termed the "M protein" (Jacob and Monod, 1961). A small number 
of "M protein" molecules are always present in the cell (basal level), 
but the high induced levels of this protein facilitate the uptake of 
lactose by the bacterial cell. In the absence of this protein the bac­
terial cell cannot incorporate lactose. It is possible that a similar 
protein is required for lactose uptake in mammalian cells, and that the 
gene coding for this protein was not activated by the methods employed. 
Furthermore, the procedure used may have been too simple. Perhaps 
there are other factors that play a role in the activation of the enzyme 
in mammalian cells. In £. coli the transcription of the beta-galactosi-
dase gene requires cyclic AMP (3', 5'-cyclic adenylic acid) (Zubay and 
Beckwith, 1970). 
Lactase activity in the mouse is maximal immediately after birth and 
decreases dramatically after weaning (2-3 weeks later). It was expected 
that epithelial intestinal cells from fetal mice would retain their abil­
ity to synthesize lactase in vitro. However, all attempts to establish a 
permanent line of these cells in culture were unsuccessful (Table 11). 
The selective medium containing lactose did not support growth of any 
cell type isolated. 
Other workers (Harrer et , 1964; Stern and Jensen, 1966; Browning 
and Trier, 1969) have also been unable to establish small intestinal 
epithelial cells in culture. The cells of the small intestine are known 
to have a very short life span even in vivo. This may account for failures 
in attempts to establish these cells in culture, i.£., it is possible that 
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the epithelial cells have been genetically programmed to undergo only a 
finite number of divisions. There are cell types for which this is true. 
For example, fibroblasts are capable of undergoing only 37 passages (111 
generations) in vitro. These cells can become permanent lines only if 
they are transformed; transformation is presumably always the result of 
viral infection. Attempts were made in this study to purposely transform 
the epithelial cells with SV-40 virus. There was no evidence of trans­
formation of these cells following infection with this virus. In future 
studies it may be worthwhile to try transforming these intestinal cells 
with other viruses; for example, Rous Sarcoma and Polyoma. SV-40 virus 
has been used successfully in the purposeful transformation of fibroblast 
cells (Todaro and Green, 1964). 
Treatment of GF9 cells with the base substitution mutagens, EMS and 
NG, yielded a total of 3707 colonies in selective medium, ]_.&.» medium in 
which lactose was the only carbon source provided. Fourteen hundred of 
these putative mutants were isolated and subcultured immediately in liquid 
selective medium to test their ability to utilize lactose in suspension 
cu l ture .  None o f  the tested co lon ies proved to  be t rue lac*  mutants ,  i .e . ,  
cells capable of using lactose as a carbon source. Although only 1400 of 
the 3707 recovered colonies were screened in this manner, it is not prob­
able that the remaining 2307 colonies contained any true lac* mutants. 
Assuming that there might have been such a mutant in this population of 
clones, it would have to occur at a very low frequency. 
The colonies which appeared after treatment with mutagens were re­
ferred to as "lactose selection variants". Control experiments (Table 6) 
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showed that these variants did not arise spontaneously, but were the re­
sult of mutagenic action. 
The selection system used in this part of the study was very straight­
forward and should have given rise to clones of the desired phenotype, 
i.e., the permanent acquisition of the ability to utilize lactose. Since 
this was not the case, attempts were made to determine the event(s) re­
sponsible for the appearance of "lactose selection variants" in the se­
lective medium. Four possibilities were considered: 
1. The variant colonies may have resulted from growth on residual 
glucose or galactose in the selective medium. 
2. The variants may have appeared as a result of cross-feeding 
between cells cloned as clumps rather than as individual cells. 
3. The variant colonies may have been capable of utilizing lactose 
only in agar culture and therefore were unable to grow in sus­
pension culture. 
4. The variants may have appeared because of an unstable "lac con­
dition" in which some of the mutagenized cells were able to 
utilize lactose for a brief period due to a temporary pro­
duction of lactase. 
Each of these suggested events for the appearance of "lactose se­
lection variants" was examined. The variants did not result from growth 
on residual glucose or galactose in the selective medium since neither of 
these monosaccharides could be detected by any of the methods employed. 
Mutagen treated cells were cloned in a medium lacking an added carbon 
source (Table 8); no colonies were obtained. Therefore, the variants were 
104 
not the result of cross-feeding. Also the "lactose selection variants" 
were not capable of utilizing lactose only in agar culture. This was evi­
dent when these variants could not be recloned in the selective cloning 
medium immediately following isolation. However, it seems that the var­
iants may have appeared in the selection system because of a chromosomal 
imbalance (Figures 10-12) which, in theory, may have allowed a transitory 
utilization of the carbon source (probably only lactose) provided. 
In regard to the latter conclusion, it was shown that there were 
significant differences in both chromosome number and patterns of dis­
tribution between the parental cells and four of the eight variants 
tested. This was the only abnormal event correlating with the appearance 
of "lactose selection variants" which could be detected. 
If mutagen-induced chromosomal instability was the event responsible 
for the appearance of the "lactose selection variants", and it is assumed 
that lactose was the only carbon source available (this is likely from 
data presented), one might hypothesize that this chromosome instability 
might have caused a temporary ability to utilize lactose. 
Attempts were made to detect the enzyme in single clones as soon as 
they became visible in the selective cloning medium using ONPG as a sub­
strate; no enzyme activity was observed. However, this observation may 
not be significant since the studies of Gray and Santiago (1959) show 
that mammalian lactase has very little capability of hydrolyzing syn­
thetic substrates. 
Terzi (1974) encountered a similar situation of chromosomal im­
balance in attempting to isolate bromodeoxyuridine and thioguanine 
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resistant mutants from a line of Syrian Hamster cells. This investi­
gator found that the putative mutants isolated from his selection sys­
tem were not true drug resistant mutants, but were mutagen-induced 
variants that had been able to grow in the selective medium because of 
a variation in chromosome number. These pseudo drug resistant mutants 
were characterized by a high phenotypic reversion rate (drug resistance » 
drug sensitivity). 
A high phenotypic reversion rate (lac^-^ lac") would explain why 
the variants isolated in this study were not able to utilize lactose in 
suspension culture following their isolation from the selective cloning 
medium. This high reversion rate is probable if it is assumed that the 
lac* phenotype was due to abnormal chromosome numbers and that among the 
mutagen treated cells there is a natural selection for cells with normal 
karyotypes. Cells with low chromosome numbers would be eliminated quick­
ly in lymphocyte cultures. If so, this would also explain why only 50 
percent and not 100 percent of the variants analyzed had chromosomal ab­
normality. 
This study is only the second in which a chromosomal loss or in­
stability has been found to give rise to a selected phenotype following 
mutagenesis. This finding is an important one in that it helps define the 
necessary parameters in the process of obtaining true mutants in mammalian 
cells. 
Bromodeoxyuridine and dimethyl sulphoxide, two chemicals which have 
been shown to inhibit and induce differentiation (see Literature Review) 
in a number of in vitro cell systems, had no effect on GF9 cells. It 
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appears that these cells are not susceptible to the actions of these 
agents. 
Therefore, in conclusion, using the three approaches outlined above, 
I was not able to establish a mammalian cell line in culture that active­
ly produces the lactase enzyme. This study, to my knowledge, represents 
the first attempt to provide an in vitro system for the study of the 
mechanisms controlling the lactase enzyme in mammalian cells. 
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